You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.


Go back

Bexsero teenage

In Ireland, Bexsero is indicated for MenB vaccination starting from 2 months of age, including infants, toddlers, children, adolescents and adults.

Click here to learn more about Meningitis in Adolescents.

Vaccines Ordering Information

Discover more about vaccines ordering information.

Find out more

Adverse events should be reported to the Health Products Regulatory Authority (HPRA) using an Adverse Reaction Report Form obtained either from the HPRA or electronically via the website at Adverse reactions can also be reported to the HPRA by calling: (01) 6764971. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255

Bexsero is a registered trademark of the GlaxoSmithKline Group of Companies